Emerging role of endothelial and inflammatory markers in preeclampsia

Disease Markers

Volumn 26, Issue 3, 2009, Pages 127-133

  Swellam, Menha ^a   Samy, Nervana ^a   Wahab, Susan Abdl ^b   Ibrahim, Mohamed Saeed ^b  

^a NATIONAL RESEARCH CENTRE   (Egypt)

^b AIN SHAMS UNIVERSITY   (Egypt)

Author keywords

Adhesion molecules; CRP; IL 6; Inflammatory markers; PAI 1; Pre eclampsia; Thrombomodulin

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 6; PLASMINOGEN ACTIVATOR INHIBITOR 1; THROMBOMODULIN;

ADULT; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; PREECLAMPSIA; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY;

EID: 68649114818     PISSN: 02780240     EISSN: None     Source Type: Journal    
DOI: 10.3233/DMA-2009-0622     Document Type: Article

References (24)

1. J.M. Roberts, R.N. Taylor, T.J. Musci, G.M. Rodgers, C.A. Hubel and M.K. McLaughlin, Preeclampsia: an endothelial cell disorder, Am J Obstet Gynecol 161 (1989), 1200-1204.
2. C.W.G. Redman and I.L. Sargent, The pathogenesis of pre-eclampsia, Gynécol Obstét Fertil 29 (2001), 518-522.
3. K. Duckitt and D. Harrington, Risk factors for pre-eclampsia at antenatal blooking: systemic review of controlled studies, BMJ 330 (2005), 565-573.
4. D.B. Carr, M.Epplein, C.O. Johnson, T.R. Easterling and C.W. Critchlow, A sister's risk: Family history as a predictor of preeclampsia, Am J Obstet and Gynecol 193 (2005), 965-972.
5. L.M. Bodnar, Low vitamin D level early in pregnancy increases preeclampsia risk 500 percent, Health Bulltein 9 (2007), 3517-3120.
6. C. Lam, K.-H. Lim and S.A. Karumanchi, Circulating Angio-genic Factors inthe Pathogenesis and Prediction of Preeclamp-sia, Hypertension 46 (2005), 1077-1085.
7. A. Remkova, E. Kovacova, M. Prýkazska and H. Kra- tochvýl'ova, Thrombomodulin as a marker of endothelium damagein some clinical conditions, Europ J Internal Medicine 11 (2000), 79-84.
8. Y. Hashimoto, A. Kobayashi, N. Yamazaki, Y. Sugawara, Y. Takada and A. Takada, Relationship between age and plasma t-PA, PA-inhibitor, and PA activity, Thromb Res 46 (1987), 625-633.
9. W. Pitiphat, M.W. Gillman, K.J. Joshipura, P.L. Williams, C.W. Douglass and J.W. Rich-Edwards, Plasma C-Reactive Protein in early pregnancy and preterm delivery, Am J Epidemiol 162 (2005), 1108-1113.
10. P. Takacs, K.L. Green, A. Nikaeo and S.W. Kauma, Increased vascular endothelial cell production of interleukin-6 in severe preeclampsia, Am J Obstet and Gynecol 188 (2003), 740-744.
11. K.H. Lim and M.M. Watkins, Preeclampsia, eclampsia, and hypertension, in: Current Clinical Pathology: Handbook of Clinical Laboratory Testing During Pregnancy, A.M. Gronowski, ed., Totowa, NJ: Humana Press; 2004, pp/ 391-400.
12. A.C.O.G. Committee on Obstetric Practice. ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Number 33, January 2002. American College of Obstetricians and Gynecologists, Int J Gynaecol Obstet 77 (2002), 67-75.
13. R.M. Loreth, C.H. Seus, H.H. Berger and F.W. Albert, Plasma thrombomodulin concentrations in healthy persons depend on age and sex, Annals of Hematology 74(Suppl II) (1997), A89-A94.
14. E. Eriksson, M. Ranby, E. Gyzander and B. Risberg, Determination of plasminogen activator inhibitor in plasma using t-PA and a chromogenic single-point poly-D-lysine stimulated assay, Thromb Res 50 (1988), 91-101.
15. N. Rifai, R. Tracy and P. Ridker, Clinical efficacy of an automated high-sensitivity C-reactive protein assay, Clin Chem 45 (1999), 2136-2141.
16. O. Le Moineo, Interleukin-6: an early marker of bacterial infectionin decompensated cirrhosis. J. Hepatology 20(1994), 819-824.
17. Zweig MH and Campbell G Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine, Clin Chem 39 (1993), 561-577.
18. N. Ilhan, N. lhan and M. Simsek, The changes of trace elements, malondialdehyde levels and superoxide dismutase activities in pregnancy with or without preeclampsia, Clin Biochem 35 (2002), 393-397.
19. J.M. Roberts and K.Y. Lain, Recent Insights into the Patho-genesis of Pre-eclampsia, Placenta 23 (2002), 359-372.
20. S.K. Nadar, E.A. Yemeni, A.D. Blann and G.Y.H. Lip, Throm-bomodulin, von Willbrand factor and E-selectin as plasma markers of endothelial damage/dysfunction and activation in pregnancy induced hypertension, Thromb Res 113 (2004), 123-128.
21. S. Guller, Y. Ma, A. Malek, S.D. Santo and H. Schneider, Differential Release of Plasminogen Activator Inhibitors (PAIs) During Dual Perfusion of Human Placenta: Implications in Preeclampsia, Placenta 28 (2007), 278-285.
22. A. Estelles, J. Gilabert, M. Keeton, Y. Eguchi, J. Aznar, S. Grancha et al., Altered expression of plasminogen activator inhibitor type 1 in placentas from pregnant women with preeclampsia and/or intrauterine fetal growth retardation, Blood 84 (1994), 143-145.
23. D.J. Freeman, F. McManus, E.N. Brown, L. Cherry, J. Nor-rie, J.E. Ramsay, P. Clark, I.D. Walker, N. Sattar and I.A. Greer, Short- and Long-Term Changes in Plasma Inflammatory Markers Associated With Preeclampsia, Hypertension 43 (2004), 708-714.
24. N.G. Than, R. Remero, R. Hillermann, V. Cozzi, G. Nie and B. Huppertz, Prediction of preeclampsia - A workshop report, Placenta 22 (2008), S83-S85.